Home > M&A deals 2003 > ABN AMRO Participaties BV and Gilde Healthcare invest in GlycArt Biotechnology AG

Venture · Life Science · November 2003

ABN AMRO Participaties BV and Gilde Healthcare invest in GlycArt Biotechnology AG

On November 26, 2003, ABN AMRO Participaties BV and Gilde Healthcare invested in GlycArt Biotechnology AG, a life science company in Switzerland.

Deal at a glance

AnnouncedNovember 26, 2003 TypeVenture TargetGlycArt Biotechnology AG Buyers ABN AMRO Participaties BV
Gilde Healthcare SectorLife Science LocationSwitzerland ValueNot disclosed

Target company

GlycArt Biotechnology AG

Switzerland

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyers (2)

ABN AMRO Participaties BV Lead

Private equity firm · 67 deals on record

Gilde Healthcare Co-investor

Company · 25 deals on record

1st transaction for the lead buyer in life science
1st transaction in Switzerland

67deals, all time

2in this sector

2011latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

FGen AGSame sector and country · Mar 2022

Questions about this deal

Who acquired GlycArt Biotechnology AG?ABN AMRO Participaties BV and Gilde Healthcare invested in GlycArt Biotechnology AG on November 26, 2003.

What type of deal was it?It was a venture in the life science sector in 2003.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).